ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Immunovia Ab (publ)

Immunovia Ab (publ) (0G8X)

191,40
0,00
( 0,00% )
Aktualisiert: 01:00:00

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
191,40
Gebot
0,00
Fragen
0,00
Volumen
0,00
0,00 Tagesbereich 0,00
191,40 52-Wochen-Bereich 191,40
Marktkapitalisierung
Handelsende
191,40
Handelsbeginn
-
Letzte Trade
(O)
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
1.808
Ausgegebene Aktien
45.287.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,02
Gewinn pro Aktie (EPS)
-6,83
Erlöse
1,65M
Nettogewinn
-309,44M

Über Immunovia Ab (publ)

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Hauptsitz
Lund, Swe
Gegründet
-
Immunovia Ab (publ) is listed in the Surgical,med Instr,apparatus sector of the Londoner Börse with ticker 0G8X. The last closing price for Immunovia Ab (publ) was SEK191,40. Over the last year, Immunovia Ab (publ) shares have traded in a share price range of SEK 191,40 to SEK 191,40.

Immunovia Ab (publ) currently has 45.287.000 shares in issue. The market capitalisation of Immunovia Ab (publ) is SEK8,67 billion. Immunovia Ab (publ) has a price to earnings ratio (PE ratio) of -0.02.

0G8X Neueste Nachrichten

Immunovia announces financial calendar for financial year 2024

Immunovia announces financial calendar for financial year 2024 PR Newswire LUND, Sweden, Jan. 4, 2024 LUND, Sweden, Jan. 4, 2024 /PRNewswire/ -- Immunovia, a diagnostic company with the vision to...

Immunovia announces financial calendar for financial year 2024

Immunovia announces financial calendar for financial year 2024 PR Newswire LUND, Sweden, Jan. 4, 2024 LUND, Sweden, Jan. 4, 2024 /PRNewswire/ -- Immunovia, a diagnostic company with the vision to...

Bulletin from the extraordinary general meeting in Immunovia AB

Bulletin from the extraordinary general meeting in Immunovia AB PR Newswire LUND, Sweden, Nov. 21, 2023 LUND, Sweden, Nov. 21, 2023 /PRNewswire/ -- On 21st November 2023, an extraordinary general...

Bulletin from the extraordinary general meeting in Immunovia AB

Bulletin from the extraordinary general meeting in Immunovia AB PR Newswire LUND, Sweden, Nov. 21, 2023 LUND, Sweden, Nov. 21, 2023 /PRNewswire/ -- On 21st November 2023, an extraordinary general...

Immunovia Publishes Interim Report for January-September 2023

Immunovia Publishes Interim Report for January-September 2023 PR Newswire LUND, Sweden, Nov. 9, 2023 LUND, Sweden, Nov. 9, 2023 /PRNewswire/ -- July-September 2023 Net sales amounted to KSEK 488...

Immunovia Publishes Interim Report for January-September 2023

Immunovia Publishes Interim Report for January-September 2023 PR Newswire LUND, Sweden, Nov. 9, 2023 LUND, Sweden, Nov. 9, 2023 /PRNewswire/ -- July-September 2023 Net sales amounted to KSEK 488...

Immunovia successfully completes discovery phase of next-generation test development

Immunovia successfully completes discovery phase of next-generation test development PR Newswire LUND, Sweden, Nov. 7, 2023 LUND, Sweden, Nov. 7, 2023 /PRNewswire/ -- Immunovia (Nasdaq Stockholm:...

Immunovia successfully completes discovery phase of next-generation test development

Immunovia successfully completes discovery phase of next-generation test development PR Newswire LUND, Sweden, Nov. 7, 2023 LUND, Sweden, Nov. 7, 2023 /PRNewswire/ -- Immunovia (Nasdaq Stockholm:...

Invitation to Immunovia's Q3 presentation

Invitation to Immunovia's Q3 presentation PR Newswire LUND, Sweden, Nov. 2, 2023 LUND, Sweden, Nov. 2, 2023 /PRNewswire/ -- Immunovia will publish its third quarter 2023 results on November 9...

Invitation to Immunovia's Q3 presentation

Invitation to Immunovia's Q3 presentation PR Newswire LUND, Sweden, Nov. 2, 2023 LUND, Sweden, Nov. 2, 2023 /PRNewswire/ -- Immunovia will publish its third quarter 2023 results on November 9...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
100191.4191.4191.400DE
400191.4191.4191.4500191.4DE
1200191.4191.4191.41808191.4DE
2600191.4191.4191.41329191.4DE
5200191.4191.4191.42436191.4DE
15600191.4191.4191.41919191.4DE
26000191.4191.4191.41272191.4DE
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
FARFerro-alloy Resources Limited
6,20p
(163,83%)
34,89M
VELAVela Technologies Plc
0,0075p
(36,36%)
299,3M
ROCRockpool Acquisitions Plc
2,25p
(28,57%)
150k
RCGHRc365 Holding Plc
1,60p
(28,00%)
3,01M
CASPCaspian Sunrise Plc
3,50p
(25,00%)
10,79M
NTOGNostra Terra Oil And Gas Company Plc
0,02325p
(-38,00%)
953,53M
CNNCaledonian Trust Plc
35,00p
(-36,36%)
98,57k
SLFRSlf Realisation Fund Limited
1,02p
(-27,66%)
293,37k
QUIZQuiz Plc
4,02p
(-23,43%)
18,99k
PPSProton Motor Power Systems Plc
0,145p
(-19,44%)
6,75M
NTOGNostra Terra Oil And Gas Company Plc
0,02325p
(-38,00%)
953,53M
NTVONativo Resources Plc
0,0023p
(0,00%)
517,78M
TRPTower Resources Plc
0,028p
(1,82%)
466,76M
VELAVela Technologies Plc
0,0075p
(36,36%)
299,3M
HAYDHaydale Graphene Industries Plc
0,115p
(0,00%)
268,58M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock